Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathurin Fumery

Showing results (91-100 of 254) with videos related to

Pageof 26
Sort By:
BMC Health Services Research|November 5, 2022
Budget impact analysis of the subcutaneous infliximab (CT-P13 SC) for treating inflammatory bowel disease in the Big-5 European (E5) countriesHyun Kyeong Yoo, Han Geul Byun, Flavio Caprioli, et al.
Chemosphere|June 10, 2022
How advanced are we on the consequences of oral exposure to food contaminants on the occurrence of chronic non communicable diseases?Lucien Grados, Maxime Pérot, Nicolas Barbezier, et al.
The American Journal of Gastroenterology|April 30, 2019
Correction: No Benefit of Concomitant 5-Aminosalicylates in Patients With Ulcerative Colitis Escalated to Biologic Therapy: Pooled Analysis of Individual Participant Data From Clinical TrialsSiddharth Singh, James Proudfoot, Parambir S Dulai, et al.
Clinics and Research in Hepatology and Gastroenterology|November 3, 2025
Diagnosis and management of patients with Crohn's disease. Position paper from the GETAIDAurélien Amiot, Anthony Buisson, Jean Marc Gornet, et al.
Best Practice & Research. Clinical Gastroenterology|August 6, 2025
Treatment sequencing in inflammatory bowel disease: Towards clinical precision medicineLéa Sequier, Bénédicte Caron, Sailish Honap, et al.
Inflammatory Bowel Diseases|April 21, 2017
Defining the Most Appropriate Delivery Mode in Women with Inflammatory Bowel Disease: A Systematic ReviewArthur Foulon, Jean-Louis Dupas, Charles Sabbagh, et al.
Clinics and Research in Hepatology and Gastroenterology|March 1, 2022
Complete endoscopic healing is associated with lower disability than partial endoscopic healing in Crohn's disease: A prospective multicenter studyClara Yzet, Franck Brazier, Virginie Sebbagh, et al.
The Lancet. Gastroenterology & Hepatology|August 21, 2018
Comparative efficacy and tolerability of pharmacological agents for management of mild to moderate ulcerative colitis: a systematic review and network meta-analysesNghia H Nguyen, Mathurin Fumery, Parambir S Dulai, et al.
Acta Obstetricia Et Gynecologica Scandinavica|May 28, 2024
Factors associated with decreased ovarian reserve in Crohn's disease: A systematic review and meta-analysisArthur Foulon, Nicolas Richard, Camille Guichard, et al.
The American Journal of Gastroenterology|June 22, 2018
No Benefit of Concomitant 5-Aminosalicylates in Patients With Ulcerative Colitis Escalated to Biologic Therapy: Pooled Analysis of Individual Participant Data From Clinical TrialsSiddharth Singh, James A Proudfoot, Parambir S Dulai, et al.
Pageof 26

Showing results (91-100 of 254) with videos related to

Sort By:
Pageof 26
BMC Health Services Research|November 5, 2022
Budget impact analysis of the subcutaneous infliximab (CT-P13 SC) for treating inflammatory bowel disease in the Big-5 European (E5) countriesHyun Kyeong Yoo, Han Geul Byun, Flavio Caprioli, et al.
Chemosphere|June 10, 2022
How advanced are we on the consequences of oral exposure to food contaminants on the occurrence of chronic non communicable diseases?Lucien Grados, Maxime Pérot, Nicolas Barbezier, et al.
The American Journal of Gastroenterology|April 30, 2019
Correction: No Benefit of Concomitant 5-Aminosalicylates in Patients With Ulcerative Colitis Escalated to Biologic Therapy: Pooled Analysis of Individual Participant Data From Clinical TrialsSiddharth Singh, James Proudfoot, Parambir S Dulai, et al.
Clinics and Research in Hepatology and Gastroenterology|November 3, 2025
Diagnosis and management of patients with Crohn's disease. Position paper from the GETAIDAurélien Amiot, Anthony Buisson, Jean Marc Gornet, et al.
Best Practice & Research. Clinical Gastroenterology|August 6, 2025
Treatment sequencing in inflammatory bowel disease: Towards clinical precision medicineLéa Sequier, Bénédicte Caron, Sailish Honap, et al.
Inflammatory Bowel Diseases|April 21, 2017
Defining the Most Appropriate Delivery Mode in Women with Inflammatory Bowel Disease: A Systematic ReviewArthur Foulon, Jean-Louis Dupas, Charles Sabbagh, et al.
Clinics and Research in Hepatology and Gastroenterology|March 1, 2022
Complete endoscopic healing is associated with lower disability than partial endoscopic healing in Crohn's disease: A prospective multicenter studyClara Yzet, Franck Brazier, Virginie Sebbagh, et al.
The Lancet. Gastroenterology & Hepatology|August 21, 2018
Comparative efficacy and tolerability of pharmacological agents for management of mild to moderate ulcerative colitis: a systematic review and network meta-analysesNghia H Nguyen, Mathurin Fumery, Parambir S Dulai, et al.
Acta Obstetricia Et Gynecologica Scandinavica|May 28, 2024
Factors associated with decreased ovarian reserve in Crohn's disease: A systematic review and meta-analysisArthur Foulon, Nicolas Richard, Camille Guichard, et al.
The American Journal of Gastroenterology|June 22, 2018
No Benefit of Concomitant 5-Aminosalicylates in Patients With Ulcerative Colitis Escalated to Biologic Therapy: Pooled Analysis of Individual Participant Data From Clinical TrialsSiddharth Singh, James A Proudfoot, Parambir S Dulai, et al.
Pageof 26